China Aoxing Pharmaceutical Company, Inc. (CAXG.OB) Announces Renewal of GMP Certification
China Aoxing Pharmaceutical Company, Inc., a pharmaceutical company located in China specializing in research, development, manufacturing and distribution of a variety of narcotics and pain-management products, announced this morning that it has received renewal of the Good Manufacturing Practice (GMP) certification for its capsule formulation and packaging production facility. The certificate of compliance was issued after a site inspection by the State Food and Drug Administration (SFDA). GMP compliance guarantees that pharmaceuticals, active ingredients and medical devices are manufactured and quality-controlled in accordance with state-of-the-art standards. According to the National Medicine Administration Law of the People's Republic of China, all…